Health Care Equipment & Services

Pro Medic Ltd. (PMU) offers a leading health‑tech billing platform that cuts imaging claim time by 40% and boosts revenue cycles; its valuation at 22.5x P/E shows a discount vs. CSL and Cochlear, making it a compelling entry point for investors amid…

BD’s Revello covered stent earns CE mark, offering a low‑profile, ultrathin PTFE design that tackles restenosis in iliac arteries and expands the company’s EU vascular portfolio.

Swiss market dips on Middle‑East tensions; Sonova Holding’s steady safety, efficacy, and regulatory focus keeps it resilient amid sector swings.

Siemens Healthineers partners with AI firm Cortechs.ai to launch NeuroQuant neuro‑imaging, boosting its digital diagnostics and positioning for a potential de‑merger to sharpen focus and grow market share.

Fresenius SE’s March 3, 2026 voting‑rights filing shows subtle shifts in shareholder power that could signal future M&A moves, stronger data‑privacy focus, and greener capital allocation, while keeping core financials stable.

Pro Medicus Ltd. (ASX: PME) offers a high‑growth, software‑centric health‑tech model that boosts imaging, reporting, and appointment efficiency while meeting strict safety and regulatory standards.

Quest Diagnostics launches an AI‑powered companion in MyQuest, boosting patient engagement and revenue while improving care quality and operating margins.

Boston Scientific expands its Farapulse CE‑marking to treat persistent atrial fibrillation, boosting clinical value and revenue potential in Europe while navigating reimbursement and operational challenges.

Smith & Né phew plc beats Q4 guidance, fuels 2025 targets and unveils handheld‑robotic orthopaedic tech for AAOS 2026, driving investor interest and future growth potential.

ResMed’s latest global sleep survey shows sleep is a priority over diet, yet access gaps persist. The article explains how the company’s AI‑driven tech, pricing, and reimbursement strategies aim to boost sleep‑disorder care while navigating market g…